文献速递消化道肿瘤放疗放疗物理与技术

直肠癌短程与长程放疗中计划选择自适应治疗的剂量学获益

Dosimetric benefit of an adaptive treatment by means of plan selection for rectal cancer patients in both short and long course radiation therapy.
PubMed 文献 · Radiat Oncol · 2020-01-13

本研究比较直肠癌自适应放疗(ART,计划选择)与非自适应放疗的靶区覆盖及危及器官剂量。纳入20例患者,长程10例(25×2Gy)、短程10例(5×5Gy),基于每日CBCT选择三计划库中最适计划。结果显示ART维持靶区覆盖,并降低膀胱和小肠剂量,但绝对差异较小。

要点

  • ART维持靶区覆盖,非ART 98.3% vs ART 99.0%(p=0.878)。
  • 长程放疗中小肠V15Gy、V40Gy、V45Gy、V95%显著降低(p<0.05),绝对差异小。
  • 两种方案膀胱所有DVH参数均显著降低(p<0.05),绝对差异小。

核心结论

  • 自适应治疗维持了靶区覆盖,并降低了危及器官剂量。

研究设计与样本

  • 纳入前20例接受自适应放疗的直肠癌患者,长程10例(25×2Gy)、短程10例(5×5Gy)。
  • 制备三个不同上段直肠系膜PTV前界margin的计划库,每日CBCT选择最适计划;另建20mm margin非自适应计划。
  • 在CBCT上勾画小肠袋、膀胱和靶区,基于所选计划与非自适应计划的剂量分布计算每日DVH。

主要发现

  • 靶区覆盖从非ART的98.3%至ART的99.0%(p=0.878)。
  • 长程放疗中小肠V15Gy、V40Gy、V45Gy和V95%在ART显著降低(p<0.05),绝对差异小。
  • 短程放疗中小肠所测DVH参数无显著差异。
  • 两种方案膀胱所有DVH参数均显著降低(p<0.05),绝对差异小。

关键数值与推荐

  • 长程方案评估剂量水平:V15Gy、V30Gy、V40Gy、V15Gy和V95%。
  • 短程方案评估剂量水平:V15Gy和V95%。

临床怎么用

  • 直肠癌短程与长程放疗中,计划选择自适应策略可在维持靶区覆盖的同时降低膀胱和小肠剂量。
  • 膀胱剂量降低在两种方案中均一致,小肠剂量降低主要见于长程方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To compare target coverage and dose to the organs at risk in two approaches to rectal cancer: a clinically implemented adaptive radiotherapy (ART) strategy using plan selection, and a non-adaptive (non-ART) strategy. METHODS: The inclusion of the first 20 patients receiving adaptive radiotherapy produced 10 patients with a long treatment schedule (25x2Gy) and 10 patients with a short schedule (5X5Gy). We prepared a library of three plans with different anterior PTV margins to the upper mesorectum, and selected the most appropriate plan on daily Conebeam CT scans (CBCT). We also created a non-adaptive treatment plan with a 20 mm margin. Bowel bag, bladder and target volume were delineated on CBCT. Daily DHVs were calculated based on the dose distribution of the selected and non-adaptive plans. Coverage of the target volume was compared per fraction between the ART and non-ART plans, as was the dose to the bladder and small bowel, assessing the following dose levels: V15Gy, V30Gy, V40Gy, V15Gy and V95% for long treatment schedules, and V15Gy and V95% for short ones. RESULTS: Target volume coverage was maintained from 98.3% (non-ART) to 99.0% (ART)(p = 0.878). In the small bowel, ART appeared to have produced significant reductions in the long treatment schedule at V15Gy, V40Gy, V45Gy and V95% (p < 0.05), but with small absolute differences. The DVH parameters tested for the short treatment schedule did not differ significantly. In the bladder, all DVH parameters in both schedules showed significant reductions (p < 0.05), also with small absolute differences. CONCLUSIONS: The adaptive treatment maintained target coverage and reduced dose to the organs at risk. TRIAL REGISTRATION: Medical Research Involving Human Subjects Act (WMO) does not apply to this study and was retrospectively approved by the Medical Ethics review Committee of the Academic Medical Center, W19_194 # 19.233.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. de Jong R, Visser J, Crama KF, et al. Dosimetric benefit of an adaptive treatment by means of plan selection for rectal cancer patients in both short and long course radiation therapy. Radiat Oncol. 2020. PMID: 31931829. doi:10.1186/s13014-020-1461-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。